Basal cell carcinoma of the eyelids

Comprehensive Ophthalmology Update

Volumn 8, Issue 1, 2007, Pages 1-14

  Prabhakaran, Venkatesh C ^a,b   Gupta, Aanchal ^a   Huilgol, Shyamala C ^a   Selva, Dinesh ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Basal cell carcinoma; Eyelids; Management; Pathology; Risk factors

Indexed keywords

ALBINISM; BASAL CELL CARCINOMA; BAZEX SYNDROME; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EXTERNAL BEAM RADIOTHERAPY; EYELID CARCINOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LASER SURGERY; LONG TERM CARE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PATIENT COUNSELING; PROGNOSIS; RADIATION EXPOSURE; REVIEW; SKIN DISEASE; XERODERMA PIGMENTOSUM;

AUSTRALIA; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; EYELID NEOPLASMS; HUMANS; INCIDENCE; NEOPLASM INVASIVENESS; ORBITAL NEOPLASMS;

EID: 34047226349     PISSN: 15277313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Miller SJ: Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 24: 1-13, 1991
2. Miller SJ: Biology of basal cell carcinoma (Part II). J Am Acad Dermatol 24: 161-75, 1991
3. Lacour JP: Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 146 Suppl 61: 17-9, 2002
4. Stanley JR, Beckwith JB, Fuller RP, et al: A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors. Cancer 50: 1486-90, 1982
5. Crowson AN: Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 19 Suppl 2: S127-47, 2006
6. Crouch HE: History of basal cell carcinoma and its treatment. J R Soc Med 76: 302-6, 1983
7. Jacob A: Observations respecting an ulcer of peculiar character, which attacks the eyelids and other parts of the face. Dublin Hospital Rep Commun Med Surg 4: 232-9, 1827
8. Margo CE, Waltz K: Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 38: 169-92, 1993
9. Staples MP, Elwood M, Burton RC, et al: Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184: 6-10, 2006
10. Rubin AI, Chen EH, Ratner D: Basal-cell carcinoma. N Engl J Med 353: 2262-9, 2005
11. Wong CS, Strange RC, Lear JT: Basal cell carcinoma. BMJ 327: 794-8, 2003
12. Miller DL, Weinstock MA: Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30: 774-8, 1994
13. Kopf AW: Computer analysis of 3531 basal-cell carcinomas of the skin. J Dermatol 6: 267-81, 1979
14. Aurora AL, Blodi FC: Lesions of the eyelids. A clinicopathological study. Surv Ophthalmol 15: 94-104, 1970
15. Kwitko ML, Boniuk M, Zimmerman LE: Eyelid tumors with reference to lesions confused with squamous cell carcinoma. I. Incidence and errors in diagnosis. Arch Ophthalmol 69: 693-7, 1963
16. Lober CW, Fenske NA: Basal cell, squamous cell, and sebaceous gland carcinomas of the periorbital region. J Am Acad Dermatol 25: 685-90, 1991
17. Gallagher RP, Hill GB, Bajdik CD, et al: Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 131: 157-63, 1995
18. Armstrong BK, Kricker A: The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63: 8-18, 2001
19. Kricker A, Armstrong BK, English DR, et al: Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer 60: 489-94, 1995
20. Lear JT, Tan BB, Smith AG, et al: Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 90: 371-4, 1997
21. Fisher BK, Warner LC: Cutaneous manifestations of the acquired immunodeficiency syndrome. Update 1987. Int J Dermatol 26: 615-30, 1987
22. Lobo DV, Chu P, Grekin RC, et al: Nonmelanoma skin cancers and infection with the human immunodeficiency virus. Arch Dermatol 128: 623-7, 1992
23. Sitz KV, Keppen M, Johnson DF: Metastatic basal cell carcinoma in acquired immunodeficiency syndrome-related complex. JAMA 257: 340-3, 1987
24. Slazinski L, Stall JR, Mathews CR: Basal cell carcinoma in a man with acquired immunodeficiency syndrome. J Am Acad Dermatol 11: 140-1, 1984
25. Jemec GB, Holm EA: Non-melanoma skin cancer in organ transplant patients. Transplantation 75: 253-7, 2003
26. Hartevelt MM, Bavinck JN, Kootte AM, et al: Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49: 506-9, 1990
27. Ewing MR: The significance of a single injury in the causation of basal-cell carcinoma of the skin. Aust N Z J Surg 41: 140-7, 1971
28. Lichter MD, Karagas MR, Mott LA, et al: Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol 136: 1007-11, 2000
29. Guo HR, Yu HS, Hu H, et al: Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC). Cancer Causes Control 12: 909-16, 2001
30. Nijsten TE, Stern RS: The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study. J Invest Dermatol 121: 252-8, 2003
31. Gorlin RJ, Vickers RA, Kellen E, Williamson JJ: Multiple basal-cell nevi syndrome. An analysis of a syndrome consisting of multiple nevoid basal-cell carcinoma, jaw cysts, skeletal anomalies, medulloblastoma, and hyporesponsiveness to parathormone. Cancer 18: 89-104, 1965
32. Taylor SF, Cook AE, Leatherbarrow B: Review of patients with basal cell nevus syndrome. Ophthal Plast Reconstr Surg 22: 259-65, 2006
33. Honavar SG, Shields JA, Shields CL, et al: Basal cell carcinoma of the eyelid associated with Gorlin-Goltz syndrome. Ophthalmology 108: 1115-23, 2001
34. Cleaver JE: Defective repair replication of DNA in xeroderma pigmentosum. Nature 218: 652-6, 1968
35. Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123: 241-50, 1987
36. Plosila M, Kiistala R, Niemi KM: The Bazex syndrome: follicular atrophoderma with multiple basal cell carcinomas, hypotrichosis and hypohidrosis. Clin Exp Dermatol 6: 31-41, 1981
37. Mérot Y, Faucher F, Didierjean L, et al: Loss of bullous pemphigoid antigen in peritumoral lacunas of basal cell carcinomas. Acta Derm Venereol 64: 209-13, 1984
38. Rippey JJ: Why classify basal cell carcinomas?. Histopathology 32: 393-8, 1998
39. Hendrix JD, Parlette HL: Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension. Arch Dermatol 132: 295-8, 1996
40. Lang PG, McKelvey AC, Nicholson JH: Three-dimensional reconstruction of the superficial multicentric basal cell carcinoma using serial sections and a computer. Am J Dermatopathol 9: 198-203, 1987
41. Saldanha G, Fletcher A, Slater DN: Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 148: 195-202, 2003
42. Slater DN, McKee PH: Minimum dataset for the histopathological reporting of common skin cancers. London, The Royal College of Pathologists, 2002, pp 1-23
43. Schuller DE, Berg JW, Sherman G, et al: Cutaneous basosquamous carcinoma of the head and neck: a comparative analysis. Otolaryngol Head Neck Surg 87: 420-7, 1979
44. Leibovitch I, McNab A, Sullivan T, et al: Orbital invasion by periocular basal cell carcinoma. Ophthalmology 112: 717-23, 2005
45. Dixon AY, Lee SH, McGregor DH: Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 11: 222-32, 1989
46. www.rcpath.org/resources/pdf/ skincancers2802.pdf. Accessed December 24, 2006
47. Ziegler A, Leffell DJ, Kunala S, et al: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 90: 4216-20, 1993
48. Saldanha G, Ghura V, Potter L, et al: Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol 151: 157-64, 2004
49. Cook J, Zitelli JA: Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 39: 698-703, 1998
50. Wesley RE, Collins JW: Basal cell carcinoma of the eyelid as an indicator of multifocal malignancy. Am J Ophthalmol 94: 591-3, 1982
51. Mavrikakis I, Malhotra R, Selva D, et al: Linear basal cell carcinoma: A distinct clinical entity. J Plast Reconstr Aesthet Surg 59: 419-23, 2006
52. Johnson TM, Tschen J, Ho C, et al: Unusual basal cell carcinomas. Cutis 54: 85-92, 1994
53. Wong VA, Marshall JA, Whitehead KJ, et al: Management of periocular basal cell carcinoma with modified en face frozen section controlled excision. Ophthal Plast Reconstr Surg 18: 430-5, 2002
54. Malhotra R, Huilgol SC, Huynh NT, et al: The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years. Ophthalmology 111: 624-30, 2004
55. Selva D, Hale L, Bouskill K, et al: Recurrent morphoeic basal cell carcinoma at the lateral canthus with orbitocranial invasion. Australas J Dermatol 44: 126-8, 2003
56. Aldred WV, Ramirez VG, Nicholson DH: Intraocular invasion by basal cell carcinoma of the lid. Arch Ophthalmol 98: 1821-2, 1980
57. Barsky D, Vasileff WJ: Extensive morphea-form basal cell carcinoma invasion of the iris and the orbital contents. Henry Ford Hosp Med J 35: 71-3, 1987
58. Lo JS, Snow SN, Reizner GT, et al: Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 24: 715-9, 1991
59. Sahl WJ: Basal cell carcinoma: influence of tumor size on mortality and morbidity. Int J Dermatol 34: 319-21, 1995
60. Randle HW: Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg 22: 255-61, 1996
61. Ting PT, Kasper R, Arlette JP: Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg 9: 10-5, 2005
62. Snow SN, Sahl W, Lo JS, et al: Metastatic basal cell carcinoma. Report of five cases. Cancer 73: 328-35, 1994
63. von Domarus H, Stevens PJ: Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10: 1043-60, 1984
64. Telfer NR, Colver GB, Bowers PW: Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. Br J Dermatol 141: 415-23, 1999
65. Kersten RC, Ewing-Chow D, Kulwin DR, et al: Accuracy of clinical diagnosis of cutaneous eyelid lesions. Ophthalmology 104: 479-84, 1997
66. Margo CE: Eyelid tumors: accuracy of clinical diagnosis. Am J Ophthalmol 128: 635-6, 1999
67. Walling HW, Fosko SW, Geraminejad PA, et al: Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 23: 389-402, 2004
68. Walker P, Hill D: Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 47: 1-12, 2006
69. Salasche SJ, Amonette RA: Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol 7: 387-94, 1981
70. Osguthorpe JD, Abel CG, Lang P, et al: Neurotropic cutaneous tumors of the head and neck. Arch Otolaryngol Head Neck Surg 123: 871-6, 1997
71. Silverman MK, Kopf AW, Bart RS, et al: Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 18: 471-6, 1992
72. Kumar P, Watson S, Brain AN, et al: Incomplete excision of basal cell carcinoma: a prospective multicentre audit. Br J Plast Surg 55: 616-22, 2002
73. Rowe DE, Carroll RJ, Day CL: Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15: 315-28, 1989
74. Khandwala MA, Lalchan SA, Chang BY, et al: Outcome of periocular basal cell carcinoma managed by overnight paraffin section. Orbit 24: 243-7, 2005
75. Hsuan JD, Harrad RA, Potts MJ, et al: Small margin excision of periocular basal cell carcinoma: 5 year results. Br J Ophthalmol 88: 358-60, 2004
76. Manstein ME, Manstein CH, Smith R: How accurate is frozen section for skin cancers?. Ann Plast Surg 50: 607-9, 2003
77. Abide JM, Nahai F, Bennett RG: The meaning of surgical margins. Plast Reconstr Surg 73: 492-7, 1984
78. Mohs FE: Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 104: 901-9, 1986
79. Wolf DJ, Zitelli JA: Surgical margins for basal cell carcinoma. Arch Dermatol 123: 340-4, 1987
80. Smeets NW, Krekels GA, Ostertag JU, et al: Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364: 1766-72, 20041319
81. Older JJ, Quickert MH, Beard C: Surgical removal of basal cell carcinoma of the eyelids utilizing frozen section control. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 79: 658-63, 1975
82. Chalfin J, Putterman AM: Frozen section control in the surgery of basal cell carcinoma of the eyelid. Am J Ophthalmol 87: 802-9, 1979
83. Doxanas MT, Green WR, Iliff CE: Factors in the successful surgical management of basal cell carcinoma of the eyelids. Am J Ophthalmol 91: 726-36, 1981
84. Conway RM, Themel S, Holbach LM: Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years. Br J Ophthalmol 88: 236-8, 2004
85. Cook BE, Bartley GB: Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 106: 746-50, 1999
86. Bialy TL, Whalen J, Veledar E, et al: Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Arch Dermatol 140: 736-42, 2004
87. Leshin B, Yeatts P, Anscher M, et al: Management of periocular basal cell carcinoma: Mohs' micrographic surgery versus radiotherapy. Surv Ophthalmol 38: 193-212, 1993
88. Avril MF, Auperin A, Margulis A, et al: Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 76: 100-6, 1997
89. Torre D: Cryosurgery of eyelid tumors, in Jakobiec FA (ed): Ocular and Adnexal Tumors. Birmingham, Aesculapius, 1978, pp 517-24
90. Anderson R: A warning on cryosurgery for eyelid malignancies. Arch Ophthalmol 96: 1289-90, 1978
91. Fraunfelder FT, Zacarian SA, Wingfield DL, et al: Results of cryotherapy for eyelid malignancies. Am J Ophthalmol 97: 184-8, 1984
92. Buschmann W: A reappraisal of cryosurgery for eyelid basal cell carcinomas. Br J Ophthalmol 86: 453-7, 2002
93. Lindgren G, Larkö O: Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol 36: 742-6, 1997
94. Bernardini FP: Management of malignant and benign eyelid lesions. Curr Opin Ophthalmol 17: 480-4, 2006
95. Peng Q, Warloe T, Berg K, et al: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79: 2282-308, 1997
96. Rhodes LE, de Rie M, Enström Y, et al: Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140: 17-23, 2004
97. Haller JC, Cairnduff F, Slack G, et al: Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 143: 1270-5, 2000
98. Vinciullo C, Elliott T, Francis D, et al: Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 152: 765-72, 2005
99. Fink-Puches R, Soyer HP, Hofer A, et al: Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 134: 821-6, 1998
100. Geisse J, Caro I, Lindholm J, et al: Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50: 722-33, 2004
101. Blasi MA, Giammaria D, Balestrazzi E: Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. Am J Ophthalmol 140: 1136-9, 2005
102. Tucker SB, Polasek JW, Perri AJ, et al: Long-term follow-up of basal cell carcinomas treated with perilesional inrerferon alfa 2b as monotherapy. J Am Acad Dermatol 54: 1033-8, 2006
103. Reymann F: Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study. Dermatologica 158: 368-72, 1979
104. Glass LF, Jaroszeski M, Gilbert R, et al: Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 37: 596-9, 1997
105. Morley M, Finger PT, Perlin M, et al: Cis-platinum chemotherapy for ocular basal cell carcinoma. Br J Ophthalmol 75: 407-10, 1991
106. Peris K, Fargnoli MC, Chimenti S: Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N Engl J Med 341: 1767-8, 1999
107. Calista D: Topical 1% cidofovir for the treatment of basal cell carcinoma. Eur J Dermatol 12: 562-4, 2002
108. Tabs S, Avci O: Induction of the differentiation and apoptosis of tumor cells in vivo with efficiency and selectivity. Eur J Dermatol 14: 96-102, 2004
109. Tilli CM, Stavast-Kooy AJ, Vuerstaek JD, et al: The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis. Arch Dermatol Res 295: 117-23, 2003
110. Giannotti B, Vanzi L, Difonzo EM, et al: The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin. Clin Exp Dermatol 28 Suppl 1: 33-5, 2003
111. Boulinguez S, Grison-Tabone C, Lamant L, et al: Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol 151: 623-6, 2004
112. National Health and Medical Research Council (NHMRC). Non-melanoma skin cancer: Guidelines for treatment and management in Australia, 2002 www.nhmrc.gov.au/ publications/synopses/ cp87syn.htm. Accessed December 24, 2006
113. Moeholt K, Aagaard H, Pfeiffer P, et al: Platinum-based cytotoxic therapy in basal cell carcinoma - a review of the literature. Acta Oncol 35: 677-82, 1996
114. Otley CC, Stasko T, Tope WD, et al: Chemoprevention of non-melanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 32: 562-8, 2006
115. Marghoob A, Kopf AW, Bart RS, et al: Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol 28: 22-8, 1993
116. Marcil I, Stern RS: Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 136: 1524-30, 2000
117. Friedman GD, Tekawa IS: Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 11: 891-7, 2000
118. Frisch M, Hjalgrim H, Olsen JH, et al: Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 125: 815-21, 1996
119. Lindelöf B, Sigurgeirsson B, Wallberg P, et al: Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 25: 245-8, 1991